Catherine Genestie

4.7k total citations
164 papers, 2.6k citations indexed

About

Catherine Genestie is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Oncology. According to data from OpenAlex, Catherine Genestie has authored 164 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 78 papers in Reproductive Medicine, 60 papers in Obstetrics and Gynecology and 46 papers in Oncology. Recurrent topics in Catherine Genestie's work include Ovarian cancer diagnosis and treatment (73 papers), Endometrial and Cervical Cancer Treatments (55 papers) and Uterine Myomas and Treatments (22 papers). Catherine Genestie is often cited by papers focused on Ovarian cancer diagnosis and treatment (73 papers), Endometrial and Cervical Cancer Treatments (55 papers) and Uterine Myomas and Treatments (22 papers). Catherine Genestie collaborates with scholars based in France, Italy and United Kingdom. Catherine Genestie's co-authors include Alexandra Léary, Philippe Morice, Jean‐Yves Scoazec, Myriam Kossaï, Sébastien Gouy, Patricia Pautier, Mojgan Devouassoux‐Shisheboran, Christine Haie-Méder, Enrica Bentivegna and Pierre Duvillard and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Catherine Genestie

147 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Catherine Genestie France	26	1.0k	831	701	668	470	164	2.6k
Masoud Azodi United States	32	1.2k 1.2×	1.0k 1.3×	809 1.2×	1.4k 2.0×	396 0.8×	162	3.3k
Kuan‐Ting Kuo Taiwan	27	778 0.8×	423 0.5×	1.1k 1.6×	643 1.0×	353 0.8×	85	2.7k
Stefan Kommoss Germany	24	1.5k 1.4×	1.3k 1.6×	461 0.7×	388 0.6×	269 0.6×	124	2.3k
Kosei Hasegawa Japan	26	940 0.9×	1.0k 1.2×	678 1.0×	1.4k 2.1×	508 1.1×	179	3.0k
Katherine Moxley United States	26	635 0.6×	788 0.9×	611 0.9×	515 0.8×	202 0.4×	71	2.0k
Christian Kainz Austria	27	719 0.7×	853 1.0×	705 1.0×	664 1.0×	269 0.6×	104	2.5k
Konstantin J. Dedes Switzerland	25	510 0.5×	327 0.4×	1.3k 1.9×	1.1k 1.7×	357 0.8×	79	2.8k
Claes Silfverswärd Sweden	32	680 0.7×	608 0.7×	525 0.7×	1.0k 1.5×	465 1.0×	109	3.4k
Ingfrid S. Haldorsen Norway	33	745 0.7×	1.2k 1.4×	561 0.8×	741 1.1×	500 1.1×	131	3.5k
Sachiko Minamiguchi Japan	28	284 0.3×	383 0.5×	300 0.4×	606 0.9×	543 1.2×	176	2.7k

Countries citing papers authored by Catherine Genestie

Since Specialization

Citations

This map shows the geographic impact of Catherine Genestie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine Genestie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine Genestie more than expected).

Fields of papers citing papers by Catherine Genestie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine Genestie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine Genestie. The network helps show where Catherine Genestie may publish in the future.

Co-authorship network of co-authors of Catherine Genestie

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine Genestie. A scholar is included among the top collaborators of Catherine Genestie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine Genestie. Catherine Genestie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Descôtes, Françoise, Jonathan Lopez, Isabelle Treilleux, et al.. (2025). Molecular Relationship Between Ovarian Sertoli-Leydig Cell Tumors and Their Heterologous Elements. The American Journal of Surgical Pathology. 50(2). 232–246.

Truffaux, Nathalène, Valérie Velasco, Laétitia Mayeur, et al.. (2025). Challenges of a tailored immunohistochemistry algorithm for uterine leiomyosarcoma: an integrated analysis of leiomyomas with bizarre nuclei and fumarate hydratase (FH) deficiency. Histopathology. 86(7). 1147–1158.

Leclerc, Julie, Catherine Genestie, Rong Chen, et al.. (2024). Updated Morphological and Immunohistochemical Profile of Neuroendocrine Tumors Developing in Ovarian Teratomas: A Large Series of a Rare and Heterogeneous Disease. International Journal of Surgical Pathology. 33(3). 605–614.

Vermij, Lisa, Alicia León‐Castillo, Melanie Powell, et al.. (2024). Clinical and Molecular Characteristics of High-Risk, Recurrent, or Metastatic Endometrial Cancer That Is Human Epidermal Growth Factor Receptor 2–Low. Journal of Clinical Oncology. 43(4). 443–452. 3 indexed citations

Grau-Béjar, Juan Francisco, Qinghe Zeng, Martin Mehnert, et al.. (2024). Exploring the tumor microenvironment (TME) in patients with mismatch repair-deficient (MMRd) endometrial cancer (EC) undergoing immune checkpoint inhibitor (ICI) therapy: Proteomic insights into immune resistance mechanisms.. Journal of Clinical Oncology. 42(16_suppl). 5609–5609.

Karabajakian, Andy, Catherine Genestie, Pierre Méeus, et al.. (2023). Adénosarcomes mullériens de l’utérus – référentiels de prise en charge du GSF-GETO/NETSARC+ et du groupe TMRG. Bulletin du Cancer. 110(7-8). 836–843. 2 indexed citations

Léary, Alexandra, Christophe Schneider, Elisa Yaniz‐Galende, et al.. (2023). CD47 expression in ovarian cancer: Dynamic correlation with lymphocyte and macrophage features as well as thrombospondin-1 (TSP-1) under neoadjuvant chemotherapy.. Journal of Clinical Oncology. 41(16_suppl). 5569–5569.

Christinat, Yann, Liza Ho, Sophie Clément, et al.. (2023). Normalized LST Is an Efficient Biomarker for Homologous Recombination Deficiency and Olaparib Response in Ovarian Carcinoma. JCO Precision Oncology. 7(7). e2200555–e2200555. 12 indexed citations

Pautier, Patricia, Catherine Genestie, Laurence Gladieff, et al.. (2023). Recommandations pour la pratique clinique Nice/Saint-Paul-de-Vence 2022–2023 : Prise en charge du cancer du col de l'utérus avancé. Bulletin du Cancer. 110(6). 6S44–6S50.

10.

Vincent, L M, Mélissa Alame, Catherine Genestie, et al.. (2023). DICER1‐mutated rhabdomyosarcoma of the ovary with teratoid features. Genes Chromosomes and Cancer. 62(12). 746–754. 3 indexed citations

11.

Blanc‐Durand, Félix, Sophie Cotteret, Catherine Genestie, et al.. (2023). Clinical Relevance of BRCA1 Promoter Methylation Testing in Patients with Ovarian Cancer. Clinical Cancer Research. 29(16). 3124–3129. 18 indexed citations

12.

Vermij, Lisa, Jan J. Jobsen, Mariël Brinkhuis, et al.. (2022). 2022-RA-568-ESGO Prognostic Relevance of FIGO grading is Limited to NSMP Endometrial Cancers. International Journal of Gynecological Cancer. 32. A97–A98. 1 indexed citations

13.

Leman, Raphaël, Étienne Muller, Nicolas Goardon, et al.. (2022). 2022-RA-935-ESGO Development of an academic genomic instability score for ovarian cancers. International Journal of Gynecological Cancer. 32. A280–A280. 1 indexed citations

14.

Auguste, Aurélie, Félix Blanc‐Durand, Marc Deloger, et al.. (2020). Small Cell Carcinoma of the Ovary, Hypercalcemic Type (SCCOHT) beyond SMARCA4 Mutations: A Comprehensive Genomic Analysis. Cells. 9(6). 1496–1496. 31 indexed citations

15.

Müller, Marie, Sophie Ferlicot, Marine Guillaud‐Bataille, et al.. (2017). Reassessing the clinical spectrum associated with hereditary leiomyomatosis and renal cell carcinoma syndrome in French FH mutation carriers. Clinical Genetics. 92(6). 606–615. 93 indexed citations

16.

Courtillot, Carine, Zeina Chakhtoura, Roman L. Bogorad, et al.. (2009). Characterization of Two Constitutively Active Prolactin Receptor Variants in a Cohort of 95 Women with Multiple Breast Fibroadenomas. The Journal of Clinical Endocrinology & Metabolism. 95(1). 271–279. 36 indexed citations

17.

Poirot, Catherine, Catherine Uzan, Marie Prades, et al.. (2008). Feasibility of ovarian cryopreservation in borderline ovarian tumours. Human Reproduction. 24(4). 850–855. 32 indexed citations

18.

Moureau-Zabotto, Laurence, S Ricci, Florence Coulet, et al.. (2006). Prognostic impact of multidrug resistance gene expression on the management of breast cancer in the context of adjuvant therapy based on a series of 171 patients. British Journal of Cancer. 94(4). 473–480. 35 indexed citations

19.

Deniaud-Alexandre, Élisabeth, et al.. (2004). Récidives locales après traitement conservateur des cancers du sein : place de la chirurgie. Bulletin du Cancer. 91(11). 821–826.

20.

Antoine, J.‐M., J Blondon, S. Uzan, et al.. (2002). Operable stages IB and II cervical carcinomas: a retrospective study comparing between preoperative uterovaginal brachytherapy and postoperative radiation therapy. Cancer/Radiothérapie. 217–237. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact